All news

Allogene Therapeutics to present at major investor conferences in Nov-Dec 2026

Alpha Vantage · Pluang · · AI-summarised by FinFlash

Allogene Therapeutics, a biotech company, announced its participation in three major investor conferences in November and December 2026: the UBS Global Biopharma Conference, Jefferies Global Healthcare Conference, and Piper Sandler Healthcare Conference. The company will provide live webcasts and replays, updating investors on its progress in developing allogeneic CAR T therapies for cancer and autoimmune diseases.

Read original source

ALLO company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.